MAM
GILD icon

Mastrapasqua Asset Management’s Gilead Sciences GILD Stock Holding History

Mastrapasqua Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$323K Buy
4,316
+145
+3% +$11.2K 0.04% 135
2023
Q2 		$321K Sell
4,171
-124
-3% -$9.89K 0.04% 134
2023
Q1 		$356K Buy
4,295
+146
+4% +$12.1K 0.04% 137
2022
Q4 		$356K Buy
4,149
+655
+19% +$51.9K 0.05% 136
2022
Q3 		$216K Buy
3,494
+150
+4% +$9.46K 0.03% 140
2022
Q2 		$207K Buy
+3,344
New +$207K 0.03% 149
2019
Q1 		– Sell
-85,982
Closed -$5.38M – 131
2018
Q4 		$5.38M Sell
85,982
-5,145
-6% -$360K 1.2% 38
2018
Q3 		$7.04M Buy
91,127
+903
+1% +$68.2K 1.33% 30
2018
Q2 		$6.39M Sell
90,224
-2,092
-2% -$148K 1.27% 33
2018
Q1 		$6.96M Buy
92,316
+1,147
+1% +$91.2K 1.42% 25
2017
Q4 		$6.53M Sell
91,169
-10,482
-10% -$796K 1.32% 28
2017
Q3 		$8.23M Buy
101,651
+979
+1% +$74.9K 1.7% 16
2017
Q2 		$7.13M Buy
100,672
+1,007
+1% +$67K 1.54% 20
2017
Q1 		$6.77M Buy
99,665
+2,309
+2% +$162K 1.51% 23
2016
Q4 		$6.97M Buy
97,356
+95
+0.1% +$7.06K 1.69% 20
2016
Q3 		$7.7M Sell
97,261
-3,138
-3% -$255K 1.89% 13
2016
Q2 		$8.38M Sell
100,399
-791
-0.8% -$70.2K 2.09% 11
2016
Q1 		$9.29M Sell
101,190
-1,747
-2% -$158K 2.17% 16
2015
Q4 		$10.4M Sell
102,937
-1,359
-1% -$141K 2.56% 6
2015
Q3 		$10.2M Sell
104,296
-270
-0.3% -$30K 2.7% 5
2015
Q2 		$12.2M Buy
104,566
+73,731
+239% +$8.06M 2.96% 2
2015
Q1 		$2.31M Sell
30,835
-75,082
-71% -$7.62M 4.57% 2
2014
Q4 		$9.98M Buy
+105,917
New +$11M 2.4% 6
2014
Q2 		$9.48M Buy
114,321
+27,111
+31% +$2.11M 2.18% 6
2014
Q1 		$6.18M Buy
87,210
+36,926
+73% +$2.9M 1.45% 29
2013
Q4 		$3.78M Sell
50,284
-4,168
-8% -$290K 0.86% 48
2013
Q3 		$3.42M Sell
54,452
-3,344
-6% -$200K 0.84% 49
2013
Q2 		$2.96M Buy
+57,796
New +$3.01M 0.79% 49

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mastrapasqua Asset Management's GILD Position: Q3 2023 in Review

Mastrapasqua Asset Management increased its Gilead Sciences (GILD) stake by 3.5% in Q3 2023, buying an estimated $11.2K and bringing the position to 4,316 shares worth $323K. The position accounts for 0.04% of the portfolio, ranked #135.

Mastrapasqua Asset Management first reported a position in GILD in Q2 2013 and has held it in 28 quarters since. The position peaked at $12.2M in Q2 2015. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Mastrapasqua Asset Management held 4,316 shares of Gilead Sciences worth $323K as of Q3 2023.
  • Mastrapasqua Asset Management bought 145 Gilead Sciences shares in Q3 2023, an estimated $11.2K.
  • Gilead Sciences made up 0.04% of Mastrapasqua Asset Management's portfolio in Q3 2023, its #135 holding.
  • Mastrapasqua Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 28 quarters since.
  • Mastrapasqua Asset Management's Gilead Sciences position peaked at $12.2M in Q2 2015.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Mastrapasqua Asset Management's 13F filing for Q3 2023, filed 25 Oct 2023.